Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling
- PMID: 36878711
- DOI: 10.1002/ijc.34491
Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling
Abstract
Detecting EBV DNA load in nasopharyngeal (NP) brushing samples for the diagnosis of nasopharyngeal carcinoma (NPC) has attracted widespread attentions. Currently, NP brush sampling mostly relies on endoscopic guidance, and there are few reports on diagnostic markers suitable for nonguided conditions (blind brush sampling), which is of great significance for extending its application. One hundred seventy nasopharyngeal brushing samples were taken from 98 NPC patients and 72 non-NPC controls under the guidance of endoscope, and 305 blind brushing samples were taken without endoscopic guidance from 164 NPC patients and 141 non-NPC controls (divided into discovery and validation sets). Among these, 38 cases of NPC underwent both endoscopy-guided NP brushing and blind brushing. EBV DNA load targeting BamHI-W region and EBV DNA methylation targeting 11029 bp CpG site located at Cp-promoter region were detected by quantitative polymerase chain reaction (q-PCR). EBV DNA load showed good classification accuracy for NPC in endoscopy-guided brushing samples (AUC = 0.984). However, in blind bushing samples, the diagnostic performance was greatly reduced (AUC = 0.865). Unlike EBV DNA load, the accuracy of EBV DNA methylation was less affected by brush sampling methods, whether in endoscopy-guided brushing (AUC = 0.923) or blind brushing (AUC = 0.928 in discovery set and AUC = 0.902 in validation set). Importantly, EBV DNA methylation achieved a better diagnostic accuracy than EBV DNA load in blind brushing samples. Overall, detection of EBV DNA methylation with blind brush sampling shows great potential in the diagnosis of NPC and may facilitate its use in nonclinical screening of NPC.
Keywords: EBV DNA load; EBV DNA methylation; NP brushing and blind brushing; diagnosis; nasopharyngeal carcinoma.
© 2023 UICC.
Similar articles
-
Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.Cancer Sci. 2020 Feb;111(2):592-600. doi: 10.1111/cas.14281. Epub 2020 Feb 5. Cancer Sci. 2020. PMID: 31834989 Free PMC article.
-
Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.Cancer Sci. 2015 Sep;106(9):1196-201. doi: 10.1111/cas.12718. Epub 2015 Jul 14. Cancer Sci. 2015. PMID: 26082292 Free PMC article.
-
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.Int J Cancer. 2017 Jan 1;140(1):149-162. doi: 10.1002/ijc.30418. Epub 2016 Sep 23. Int J Cancer. 2017. PMID: 27600027 Free PMC article.
-
Early screening of nasopharyngeal carcinoma.Head Neck. 2023 Oct;45(10):2700-2709. doi: 10.1002/hed.27466. Epub 2023 Aug 8. Head Neck. 2023. PMID: 37552128 Review.
-
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus.Hematol Oncol Clin North Am. 2021 Oct;35(5):963-971. doi: 10.1016/j.hoc.2021.05.007. Epub 2021 Jun 27. Hematol Oncol Clin North Am. 2021. PMID: 34187713 Review.
Cited by
-
Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples.BMC Cancer. 2025 Jul 5;25(1):1147. doi: 10.1186/s12885-025-14508-y. BMC Cancer. 2025. PMID: 40618071 Free PMC article.
-
Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash.MedComm (2020). 2024 Aug 19;5(9):e673. doi: 10.1002/mco2.673. eCollection 2024 Sep. MedComm (2020). 2024. PMID: 39161799 Free PMC article.
-
Blind Brush Biopsy: Quantification of Epstein-Barr Virus and Its Host DNA Methylation in the Detection of Nasopharyngeal Carcinoma.Research (Wash D C). 2024 Sep 24;7:0475. doi: 10.34133/research.0475. eCollection 2024. Research (Wash D C). 2024. PMID: 39319346 Free PMC article.
-
EBV DNA methylation profiles and its application in distinguishing nasopharyngeal carcinoma and nasal NK/T-cell lymphoma.Clin Epigenetics. 2024 Jan 11;16(1):11. doi: 10.1186/s13148-024-01624-y. Clin Epigenetics. 2024. PMID: 38212818 Free PMC article.
-
Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma.Clin Epigenetics. 2025 Feb 27;17(1):38. doi: 10.1186/s13148-025-01847-7. Clin Epigenetics. 2025. PMID: 40016817 Free PMC article.
References
REFERENCES
-
- Razak AR, Siu LL, Liu FF, Ito E, O'Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. Eur J Cancer. 2010;46(11):1967-1978.
-
- Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757-768.
-
- Niedobitek G, Young LS. Epstein-Barr virus persistence and virus-associated tumours. Lancet. 1994;343(8893):333-335.
-
- Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995;333(11):693-698.
-
- Pickard A, Chen CJ, Diehl SR, et al. Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan. Int J Cancer. 2004;111(1):117-123.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous